“Synthesis and biological evaluation of (4-Fluorophenyl)(1-(5-phenyl-1,3,4-oxadiazol-2-yl)indolizin-3-yl)methanone derivatives as anticancer and antimicrobial agents”, Int. J. Pharm. Sci. Drug Res., vol. 14, no. 1, pp. 8–18, Jan. 2022, doi: 10.25004/IJPSDR.2022.140102.